Perceptive Advisors LLC
- SEC CIK
- 0001224962
- Latest filing
- Aug 14, 2026
Holdings in Q1 2022
Holdings as of Mar 31, 2022, filed May 16, 2022. Long positions only; changes compare share counts with Q4 2021.
- Positions
- 135
- −10 vs. Q4 2021
- Portfolio value
- $4.81B
- −$1.66B (−25.6%) vs. Q4 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CLOVClover Health Investments, Corp. | COM CL A | 1,500,000 | $5.33M | 0.1% | 00.0% | Unchanged | History |
| HYPRHyperfine, Inc. | COM CL A | 1,500,000 | $5.31M | 0.1% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 494,403 | $5.29M | 0.1% | −178,949−26.6% | Reduced | History |
| NVNOenVVeno Medical Corp | COMMON STOCK | 781,615 | $4.98M | 0.1% | 00.0% | Unchanged | History |
| DALSDA32 Life Science Tech Acquisition Corp. | CLASS A COM | 500,000 | $4.86M | 0.1% | 00.0% | Unchanged | History |
| PEARPear Therapeutics, Inc. | CLASS A COM | 926,232 | $4.68M | 0.1% | 00.0% | Unchanged | History |
| SGHTSight Sciences, Inc. | COM | 390,000 | $4.51M | 0.1% | 00.0% | Unchanged | History |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 450,000 | $4.46M | 0.1% | 00.0% | Unchanged | History |
| NVTAInvitae Corp | COM | 554,585 | $4.42M | 0.1% | −1,030,000−65.0% | Reduced | History |
| IMRXImmuneering Corp | CLASS A COM | 681,051 | $4.41M | 0.1% | 00.0% | Unchanged | History |
| RLMDRelmada Therapeutics, Inc. | COM | 151,350 | $4.08M | 0.1% | +151,350 | New | History |
| NARIInari Medical, Inc. | Stock | 30,000 | $2.72M | 0.1% | +30,000 | New | History |
| RVNCRevance Therapeutics, Inc. | COM | 137,514 | $2.68M | 0.1% | +137,514 | New | History |
| SONXSonendo, Inc. | COM | 668,505 | $2.68M | 0.1% | 00.0% | Unchanged | History |
| ZYZymergen Inc. | COM | 883,332 | $2.55M | 0.1% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 65,144 | $2.38M | <0.1% | −34,856−34.9% | Reduced | History |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 596,942 | $2.33M | <0.1% | +596,942 | New | History |
| TARAProtara Therapeutics, Inc. | COM STK | 383,526 | $1.96M | <0.1% | −38,115−9.0% | Reduced | History |
| DRIODarioHealth Corp. | COM NEW | 327,869 | $1.92M | <0.1% | 00.0% | Unchanged | History |
| LENZLENZ Therapeutics, Inc. | COM | 325,854 | $1.66M | <0.1% | −524,239−61.7% | Reduced | History |
| RETAReata Pharmaceuticals Inc | CL A | 44,475 | $1.46M | <0.1% | +44,475 | New | History |
| RACEFerrari N.V. | COM | 6,200 | $1.35M | <0.1% | 00.0% | Unchanged | History |
| ONCROncorus, Inc. | COM | 752,241 | $1.34M | <0.1% | −247,571−24.8% | Reduced | History |
| RPIDRapid Micro Biosystems, Inc. | CLASS A COM | 190,745 | $1.29M | <0.1% | −194,948−50.5% | Reduced | History |
| MOTSMotus GI Holdings, Inc. | COM | 1,800,542 | $648.0K | <0.1% | 00.0% | Unchanged | History |
| NEPTFNeptune Wellness Solutions Inc. | COM | 2,000,000 | $445.0K | <0.1% | −8,055,521−80.1% | Reduced | History |
| Rockley Photonics Holdings LG7614L117 | *W EXP 08/11/202 | 500,000 | $425.0K | <0.1% | 00.0% | Unchanged | – |
| Butterfly Network, Inc.124155110 | *W EXP 05/27/202 | 233,333 | $238.0K | <0.1% | 00.0% | Unchanged | – |
| SLGCWSomaLogic, Inc. | *W EXP 03/01/202 | 110,000 | $235.0K | <0.1% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 77,723 | $234.0K | <0.1% | −335,723−81.2% | Reduced | History |
| UTRSMinerva Surgical Inc | COM | 50,268 | $226.0K | <0.1% | −37,500−42.7% | Reduced | History |
| EQRx, Inc.26886C115 | *W EXP 12/17/202 | 250,000 | $218.0K | <0.1% | 00.0% | Unchanged | – |
| CareMax, Inc.14171W111 | *W EXP 06/08/202 | 60,000 | $114.0K | <0.1% | 00.0% | Unchanged | – |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 166,666 | $42.0K | <0.1% | 00.0% | Unchanged | – |
| AGRXAgile Therapeutics Inc | COM | 21,294,485 | – | – | 00.0% | Unchanged | History |
Sold out since Q4 2021 (24)
Positions held at the end of Q4 2021 that are gone from this filing.
| Security | Class | Shares in Q4 2021 | Value in Q4 2021 | % of portfolio in Q4 2021 | History |
|---|---|---|---|---|---|
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $484.7M | 7.5% | – |
| BMRNBiomarin Pharmaceutical Inc | COM | 1,180,000 | $104.3M | 1.6% | History |
| Nevro Corp64157FAC7 | NOTE 2.750% 4/0 | – | $101.5M | 1.6% | – |
| ARNAArena Pharmaceuticals Inc | COM NEW | 500,000 | $46.5M | 0.7% | History |
| KODKodiak Sciences Inc. | COM | 520,152 | $44.1M | 0.7% | History |
| UTHRUnited Therapeutics Corp | COM | 94,064 | $20.3M | 0.3% | History |
| VTRSViatris Inc | Stock | 1,004,419 | $13.6M | 0.2% | History |
| BCABBioAtla, Inc. | COM | 661,200 | $13.0M | 0.2% | History |
| IMCRImmunocore Holdings plc | ADS | 360,000 | $12.3M | 0.2% | History |
| BIIBBiogen Inc. | COM | 48,600 | $11.7M | 0.2% | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 239,258 | $10.2M | 0.2% | History |
| ADPTAdaptive Biotechnologies Corp | COM | 352,804 | $9.90M | 0.2% | History |
| KYMRKymera Therapeutics, Inc. | COM | 155,000 | $9.84M | 0.2% | History |
| ONEM1Life Healthcare Inc | COM | 532,350 | $9.35M | 0.1% | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 229,807 | $8.88M | 0.1% | History |
| EQRXEQRx, Inc. | COM | 1,250,000 | $8.53M | 0.1% | History |
| TBIOTelesis Bio Inc. | COM | 425,000 | $4.59M | 0.1% | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 755,375 | $3.78M | 0.1% | – |
| AXSMAxsome Therapeutics, Inc. | COM | 80,420 | $3.04M | <0.1% | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 125,000 | $2.89M | <0.1% | History |
| YARWYarrow Bioscience, Inc. | COM | 2,178,022 | $2.22M | <0.1% | History |
| ITOSiTeos Therapeutics, Inc. | COM | 20,000 | $931.0K | <0.1% | History |
| EIGREiger BioPharmaceuticals, Inc. | COM | 139,890 | $726.0K | <0.1% | History |
| PHVSPharvaris N.V. | COM | 27,000 | $389.0K | <0.1% | History |